Increased expression of the vascular endothelial growth factor is a pejorative prognosis marker in papillary thyroid carcinoma

Journal of Clinical Endocrinology and Metabolism

Volumn 86, Issue 2, 2001, Pages 656-658

  Klein, M ^a,b   Vignaud, J M ^a   Hennequin, V ^a   Toussaint, B ^a   Bresler, L ^a   Plenat F ^a   Leclere J ^a   Duprez, A ^a   Weryha, G ^a  

^a UNIVERSITY HOSPITAL OF NANCY   (France)

^b CHU NANCY BRABOIS   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGE; AGED; ARTICLE; CANCER RISK; CELL PROLIFERATION; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HIGH RISK PATIENT; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; METASTASIS; PATIENT MONITORING; PRIORITY JOURNAL; PROGNOSIS; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; THYROGLOBULIN BLOOD LEVEL; THYROID CARCINOMA; TUMOR VOLUME;

EID: 0035090293     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jcem.86.2.7226     Document Type: Article

References (25)

1. Expression of vascular endothelial growth factor and its receptors in human renal ontogenesis and in adult kidney
2. The biology of vascular endothelial growth factor
3. Vascular endothelial growth factor: Basic biology and clinical implications
4. Significance of vascular endothelial growth factor/vascular permeability factor for solid tumor growth, and its inhibition by the antibody
5. Regulations of vasculatropin/vascular endothelial growth factor bioavailability
6. Vascular endothelial growth factor is a potential tumour angiogenesis factor in human gliomas in vivo
7. Vascular permeability factor (VPF, VEGF) in tumor biology
8. Vascular permeability factor/vascular endothelial growth factor, microvascular hyperpermeability, and angiogenesis
9. Vascular permeability factor/vascular endothelial growth factor: A multifunctional angiogenic cytokine
10. Prognostic value of vascular endothelial growth factor expression in gastric carcinoma
11. Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma
12. Expression of vascular endothelial growth factor (VEGF) in human thyroid neoplasm
13. Vascular endothelial growth factor gene and protein: Strong expression in thyroiditis and thyroid carcinoma
14. Up-regulation of vascular endothelial growth factor (VEGF) and down-regulation of placenta growth factor (PlGF) associated with malignancy in human thyroid tumors and cell lines
15. Tumor angiogenesis: Therapeutic implications
16. Angiogenesis is associated with vascular endothelial growth factor expression in cervical intraepithelial neoplasia
17. Expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in endometrial carcinoma
18. Tumor angiogenesis in breast cancer: Its importance as a prognostic indicator and the association with vascular endothelial growth factor expression
19. Vascular endothelial growth factor expression in early stage ovarian carcinoma
20. Expression of vascular endothelial growth factor (VEGF) in epithelial ovarian neoplasms: Correlation with clinicopathology and patient survival, and analysis of serum VEGF levels
21. Enhanced expression of vascular endothelial growth factor in metastatic melanoma
22. Vascular endothelial growth factor expression in head and neck squamous cell carcinoma
23. Vascular endothelial growth factor expresion is higher in differentiated thyroid cancer than in normal or benign thyroid
24. The expression of vascular endothelial growth factor and the type 1 vascular endothelial growth factor receptor correlate with the size of papillary thyroid carcinoma in children and young adults
25. Distant metastasis in papillary thyroid cancer. A review of 91 patients